Markets › United States › NAS › VRAX

Virax Biolabs Group Ltd

NAS:VRAXHealthcarenasdaq_composite

$1.24+0.40%LiveIn session · ≈ AED 4.55 · Market cap $1.67M · Next earnings Wed 2 Dec

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	−7.6%	—	−15.9%	32.3%	−838.2%	61.9%	—	—
Operating margin	−520.5%	—	−66,963.7%	−4,153.3%	−97,344.8%	−51,515.2%	−51,515.2%	+0.0 pts
Net margin	−525.8%	—	−63,748.3%	−4,304.8%	−95,739.2%	−40,439.1%	−40,439.1%	+0.0 pts
EBITDA margin	−520.3%	—	−63,570.7%	−4,225.3%	−91,649.5%	−48,685.1%	—	—
Return on equity	109.2%	175.3%	−59.8%	−125.5%	−106.4%	−66.3%	−68.5%	−2.2 pts
Return on assets	−691.7%	−3,508.5%	−55.6%	−122.8%	−94.3%	−60.3%	−60.3%	+0.0 pts
Return on capital employed	82.9%	144.9%	−64.4%	−122.2%	−107.1%	−83.8%	—	—
Debt / equity	−0.3×	−0.0×	0.0×	0.0×	0.1×	0.1×	0.1×	+3.3%
Debt / assets	190.7%	7.7%	1.5%	4.1%	5.9%	5.0%	—	—
Interest coverage	−22.5×	−112.3×	−370.6×	−241.7×	−105.9×	−103.6×	—	—
Current ratio	0.0×	0.0×	10.6×	25.9×	7.3×	10.0×	10.0×	+0.0%
Quick ratio	0.0×	0.0×	10.6×	25.6×	7.1×	9.9×	—	—
Cash ratio	0.0×	0.0×	10.3×	21.3×	6.3×	9.4×	9.4×	+0.0%
Asset turnover	1.3×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	6.3×	0.0×	0.4×	1.8×	0.6×	0.1×	—	—
Receivables turnover	133.4×	—	—	0.7×	0.2×	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—